Cooperation of chromatin remodeling SWI/SNF complex and pioneer factor AP-1 shapes 3D enhancer landscapes

BK Wolf, Y Zhao, A McCray, WH Hawk… - Nature structural & …, 2023 - nature.com
The mechanism controlling the dynamic targeting of SWI/SNF has long been postulated to
be coordinated by transcription factors (TFs), yet demonstrating a specific TF influence has …

Emerging themes in mechanisms of tumorigenesis by SWI/SNF subunit mutation

CA Jones, WP Tansey… - Epigenetics insights, 2022 - journals.sagepub.com
The SWI/SNF chromatin remodeling complex uses the energy of ATP hydrolysis to alter
contacts between DNA and nucleosomes, allowing regions of the genome to become …

[HTML][HTML] SMARCA4 and SMARCA2 co-deficiency: An uncommon molecular signature defining a subset of rare, aggressive and undifferentiated malignancies …

NR Field, KA Dickson, NT Nassif, DJ Marsh - Cancer Letters, 2024 - Elsevier
Genetic mutations and epigenetic modifications affecting multiple cancer-related genes
occur synergistically to drive tumorigenesis. Across a wide spectrum of cancers, pathogenic …

Structural and functional properties of mSWI/SNF chromatin remodeling complexes revealed through single-cell perturbation screens

JE Otto, O Ursu, AP Wu, EB Winter, MS Cuoco, S Ma… - Molecular Cell, 2023 - cell.com
Summary The mammalian SWI/SNF (mSWI/SNF or BAF) family of chromatin remodeling
complexes play critical roles in regulating DNA accessibility and gene expression. The three …

The CUT&RUN suspect list of problematic regions of the genome

A Nordin, G Zambanini, P Pagella, C Cantù - Genome Biology, 2023 - Springer
Abstract Background Cleavage Under Targets and Release Using Nuclease (CUT&RUN) is
an increasingly popular technique to map genome-wide binding profiles of histone …

[HTML][HTML] Genomic evidence suggests that cutaneous neuroendocrine carcinomas can arise from squamous dysplastic precursors

PW Harms, ME Verhaegen, K Hu, SM Hrycaj… - Modern Pathology, 2022 - Elsevier
Merkel cell carcinoma (MCC) is an aggressive cutaneous neuroendocrine carcinoma
without a known dysplastic precursor. In some cases, MCC is associated with SCCIS in the …

Alanine supplementation exploits glutamine dependency induced by SMARCA4/2-loss

X Zhu, Z Fu, SY Chen, D Ong, G Aceto, R Ho… - Nature …, 2023 - nature.com
Abstract SMARCA4 (BRG1) and SMARCA2 (BRM) are the two paralogous ATPases of the
SWI/SNF chromatin remodeling complexes frequently inactivated in cancers. Cells deficient …

SMARCA4‐deficient rhabdoid tumours show intermediate molecular features between SMARCB1‐deficient rhabdoid tumours and small cell carcinomas of the ovary …

M Andrianteranagna, J Cyrta… - The Journal of …, 2021 - Wiley Online Library
Extracranial rhabdoid tumours (ECRTs) are an aggressive malignancy of infancy and early
childhood. The vast majority of cases demonstrate inactivation of SMARCB1 …

Multiple interactions of the oncoprotein transcription factor MYC with the SWI/SNF chromatin remodeler

CM Woodley, AS Romer, J Wang, AD Guarnaccia… - Oncogene, 2021 - nature.com
The SNF5 subunit of the SWI/SNF chromatin remodeling complex has been shown to act as
a tumor suppressor through multiple mechanisms, including impairing the ability of the …

[HTML][HTML] Aberrant SWI/SNF Complex Members Are Predominant in Rare Ovarian Malignancies—Therapeutic Vulnerabilities in Treatment-Resistant Subtypes

Y Ma, NR Field, T Xie, S Briscas, EG Kokinogoulis… - Cancers, 2024 - mdpi.com
Simple Summary The rare ovarian cancer subtypes ovarian clear cell carcinoma (OCCC)
and Small cell carcinoma of the ovary, hypercalcaemic type (SCCOHT), can have mutations …